Show simple item record

Sobrevida a mediano plazo en los pacientes con hipertensión arterial pulmonar en la era de terapias vasodilatadoras específicas del territorio vascular pulmonar

SURVIVAL OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION AFTER THE ADVENT OF SPECIFIC PULMONARY VASODILATOR THERAPIES

dc.contributorningunaes-ES
dc.contributoren-US
dc.creatorHerrera, Sebastian; División de Enfermedades Cardiovasculares Pontificia Universidad Católica de Chile
dc.creatorGabrielli, Luigi; División de Enfermedades Cardiovasculares Pontificia Universidad Católica de Chile
dc.creatorParedes, Alejandro; División de Enfermedades Cardiovasculares Pontificia Universidad Católica de Chile
dc.creatorSaavedra, Rodrigo; División de Enfermedades Cardiovasculares Pontificia Universidad Católica de Chile
dc.creatorOcaranza, María Paz; División de Enfermedades Cardiovasculares Pontificia Universidad Católica de Chile
dc.creatorSepúlveda, Pablo; División de Cardiología Hospital San Juan de Dios
dc.creatorDonoso, Hernán; División de Cardiología Hospital San Juan de Dios
dc.creatorLópez, Leonel; División de Cardiología Hospital San Juan de Dios
dc.creatorVerdejo, Hugo; División de Enfermedades Cardiovasculares Pontificia Universidad Católica de Chile
dc.creatorBaraona, Fernando; División de Enfermedades Cardiovasculares Pontificia Universidad Católica de Chile
dc.creatorCastro, Pablo; División de Enfermedades Cardiovasculares Pontificia Universidad Católica de Chile
dc.date2016-07-13
dc.date.accessioned2019-11-11T18:27:55Z
dc.date.available2019-11-11T18:27:55Z
dc.identifierhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/4623
dc.identifier.urihttps://revistaschilenas.uchile.cl/handle/2250/111371
dc.descriptionBackground: Pulmonary arterial hypertension (PAH) is a rare and progressive disease. Long-term survival remains poor despite of advances in specific vasodilator therapy. Aim: To describe the survival rate in a cohort of PAH patients in two referral centers in Chile. Patients and methods: One hundred fifteen patients aged 43 ± 15.6 years (85 % females) with PAH qualified for this study. Their median pulmonary artery pressure was 55.4 ±14 mm Hg and their six minutes walking capacity was 368 ± 119 m. They were followed for 58 ± 0.4 months and their actual survival rates were compared with the estimated survival using the equation proposed by the French registry of PAH. Results: One, two and three year survival rates were 97, 94 and 89%, respectively. The observed survival rates were greater than the estimated survival. Conclusions: The improvement in survival rates observed in this cohort of patients is similar to what has been described in literature.es-ES
dc.descriptionBackground: Pulmonary arterial hypertension (PAH) is a rare and progressive disease. Long-term survival remains poor despite of advances in specific vasodilator therapy. Aim: To describe the survival rate in a cohort of PAH patients in two referral centers in Chile. Patients and methods: One hundred fifteen patients aged 43 ± 15.6 years (85 % females) with PAH qualified for this study. Their median pulmonary artery pressure was 55.4 ±14 mm Hg and their six minutes walking capacity was 368 ± 119 m. They were followed for 58 ± 0.4 months and their actual survival rates were compared with the estimated survival using the equation proposed by the French registry of PAH. Results: One, two and three year survival rates were 97, 94 and 89%, respectively. The observed survival rates were greater than the estimated survival. Conclusions: The improvement in survival rates observed in this cohort of patients is similar to what has been described in literature.en-US
dc.formatapplication/pdf
dc.languagespa
dc.publisherRevista Médica de Chilees-ES
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/4623/2253
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21011
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21012
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21013
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21014
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21015
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21016
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21017
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21018
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21117
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21118
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21119
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21120
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21121
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21122
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21123
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21124
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21125
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21126
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21127
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21128
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21229
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/21290
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/22329
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/24017
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/24018
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/4623/25103
dc.sourceRevista Médica de Chile; Vol. 144, núm. 7 (2016): JULIO 2016es-ES
dc.source0034-9887
dc.subjectFollow-Up Studies; Hypertension, Pulmonary; Registries; Survival ratees-ES
dc.subjectFollow-Up Studies; Hypertension, Pulmonary; Registries; Survival rateen-US
dc.titleSobrevida a mediano plazo en los pacientes con hipertensión arterial pulmonar en la era de terapias vasodilatadoras específicas del territorio vascular pulmonares-ES
dc.titleSURVIVAL OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION AFTER THE ADVENT OF SPECIFIC PULMONARY VASODILATOR THERAPIESen-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typees-ES


This item appears in the following Collection(s)

Show simple item record